Leslie V Farland1, Judy E Stern2, Chia-Ling Liu3, Howard J Cabral4, Charles C Coddington5, Hafsatou Diop3, Dmitry Dukhovny6, Sunah Hwang7, Stacey A Missmer8. 1. Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, AZ; Department of Obstetrics and Gynecology, The University of Arizona College of Medicine-Tucson, Tucson, AZ. Electronic address: LFARLAND@email.arizona.edu. 2. Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, Lebanon, NH. 3. Massachusetts Department of Public Health, Bureau of Family Health and Nutrition, Boston, MA. 4. Department of Biostatistics, Boston University School of Public Health, Boston, MA. 5. Department of Obstetrics and Gynecology, Atrium Health Carolinas Medical Center, Charlotte, NC. 6. Department of Pediatrics, Oregon Health & Science University, Portland, OR. 7. Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. 8. Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Abstract
BACKGROUND: Endometriosis and uterine fibroids are common gynecologic conditions associated with a greater risk for infertility. Previous research has suggested that these conditions are associated with adverse pregnancy outcomes, potentially because of increased utilization of fertility treatments. OBJECTIVE: Our objective was to investigate whether women with a history of endometriosis or fibroids had a greater risk for adverse pregnancy outcomes and whether this risk varied by infertility history and fertility treatment utilization. STUDY DESIGN: Deliveries (2013-2017) recorded in Massachusetts' vital records were linked to assisted reproductive technology data, hospital stays, and all-payer claims database. We identified endometriosis and fibroids diagnoses via the all-payer claims database before index delivery. Adjusted relative risks for pregnancy complications were modeled using generalized estimating equations with a log link and Poisson distribution. The influence of subfertility or infertility and assisted reproductive technology was also investigated. RESULTS: Among 91,825 deliveries, 1560 women had endometriosis and 4212 had fibroids. Approximately 30% of women with endometriosis and 26% of women with fibroids experienced subfertility or infertility without utilizing assisted reproductive technology, and 34% of women with endometriosis and 21% of women with fibroids utilized assisted reproductive technology for the index delivery. Women with a history of endometriosis or fibroids were at a greater risk for pregnancy-induced hypertension, preeclampsia, or eclampsia (endometriosis relative risk, 1.17; fibroids relative risk, 1.08), placental abnormalities (endometriosis relative risk, 1.65; fibroids relative risk, 1.38), and cesarean delivery (endometriosis relative risk, 1.22; fibroids relative risk, 1.17) than women with no history of those conditions. Neonates born to women with a history of endometriosis or fibroids were also at a greater risk for preterm birth (endometriosis relative risk, 1.24; fibroids relative risk, 1.17). Associations between fibroids and low birthweight varied by fertility status or assisted reproductive technology (P homogeneity=.01) and were stronger among noninfertile women. CONCLUSION: Endometriosis or fibroids increased the risk for adverse pregnancy outcomes, possibly warranting differential screening or treatment.
BACKGROUND: Endometriosis and uterine fibroids are common gynecologic conditions associated with a greater risk for infertility. Previous research has suggested that these conditions are associated with adverse pregnancy outcomes, potentially because of increased utilization of fertility treatments. OBJECTIVE: Our objective was to investigate whether women with a history of endometriosis or fibroids had a greater risk for adverse pregnancy outcomes and whether this risk varied by infertility history and fertility treatment utilization. STUDY DESIGN: Deliveries (2013-2017) recorded in Massachusetts' vital records were linked to assisted reproductive technology data, hospital stays, and all-payer claims database. We identified endometriosis and fibroids diagnoses via the all-payer claims database before index delivery. Adjusted relative risks for pregnancy complications were modeled using generalized estimating equations with a log link and Poisson distribution. The influence of subfertility or infertility and assisted reproductive technology was also investigated. RESULTS: Among 91,825 deliveries, 1560 women had endometriosis and 4212 had fibroids. Approximately 30% of women with endometriosis and 26% of women with fibroids experienced subfertility or infertility without utilizing assisted reproductive technology, and 34% of women with endometriosis and 21% of women with fibroids utilized assisted reproductive technology for the index delivery. Women with a history of endometriosis or fibroids were at a greater risk for pregnancy-induced hypertension, preeclampsia, or eclampsia (endometriosis relative risk, 1.17; fibroids relative risk, 1.08), placental abnormalities (endometriosis relative risk, 1.65; fibroids relative risk, 1.38), and cesarean delivery (endometriosis relative risk, 1.22; fibroids relative risk, 1.17) than women with no history of those conditions. Neonates born to women with a history of endometriosis or fibroids were also at a greater risk for preterm birth (endometriosis relative risk, 1.24; fibroids relative risk, 1.17). Associations between fibroids and low birthweight varied by fertility status or assisted reproductive technology (P homogeneity=.01) and were stronger among noninfertile women. CONCLUSION: Endometriosis or fibroids increased the risk for adverse pregnancy outcomes, possibly warranting differential screening or treatment.
Authors: Aude Girault; Camille Le Ray; Charles Chapron; François Goffinet; Louis Marcellin Journal: Am J Obstet Gynecol Date: 2018-08-25 Impact factor: 8.661
Authors: C S Gallagher; N Mäkinen; H R Harris; N Rahmioglu; D I Chasman; S A Missmer; K T Zondervan; C C Morton; O Uimari; J P Cook; N Shigesi; T Ferreira; D R Velez-Edwards; T L Edwards; S Mortlock; Z Ruhioglu; F Day; C M Becker; V Karhunen; H Martikainen; M-R Järvelin; R M Cantor; P M Ridker; K L Terry; J E Buring; S D Gordon; S E Medland; G W Montgomery; D R Nyholt; D A Hinds; J Y Tung; J R B Perry; P A Lind; J N Painter; N G Martin; A P Morris Journal: Nat Commun Date: 2019-10-24 Impact factor: 17.694
Authors: Se Jin Lee; Hyun Sun Ko; Sunghun Na; Jin Young Bae; Won Joon Seong; Jong Woon Kim; Jaeeun Shin; Hae Joong Cho; Gyu Yeon Choi; Jinsil Kim; Geum Joon Cho; In Yang Park Journal: BMC Pregnancy Childbirth Date: 2020-11-23 Impact factor: 3.007
Authors: Judy E Stern; Chia-Ling Liu; Sunah S Hwang; Dmitry Dukhovny; Leslie V Farland; Hafsatou Diop; Charles C Coddington; Howard Cabral Journal: J Clin Med Date: 2021-04-14 Impact factor: 4.241